Clinical trial · Observational
Feasibility of ERAS Protocol in T4 Colorectal Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients diagnosed with T4 colorectal cancer represent a specific subgroup of colorectal patients, frequently composed of fragile patients whose advanced nature of the disease often requires a multi organ resection by an open surgery approach and frequently leads to higher intra/postoperative complication.Those characteristics makes them to be considered less suitable for ERAS protocol, especially regarding an expected difficult compliance to postoperative items. The impact of enhanced recovery program on postoperative outcomes in this subset of patients has never been addressed in literature, in fact most of studies either excluded T4 patients due to higher rates of complication or adopted an homogeneous patient sampling analizing all stage colorectal cancer together. Our aim is to investigate the feasibility of ERAS protocol in T4 colorectal patient, primary outcome was to compare postoperative lenght of stay between T4 colorectal patients treated with ERAS protcol and those treated with standard of care.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| ERAS | — | UNRESOLVED | — |
| Fast Track Protocol | — | UNRESOLVED | — |
| T4 Colorectal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ERAS protocol | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- t4 colorectal cancer treated with ERAS protocol
- description
- prospective from January 2016 to May 2020
- interventionNames
- Behavioral: ERAS protocol
- label
- t4 colorectal cancer treated with standards of care
- description
- retrospective from January 2010 to December 2015
Primary outcomes (1)
- measure
- Postoperative length of stay
- timeFrame
- 30 days
- description
- number of days from surgery to discharge
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * colorectal cacer * hystologic diagnosis of adenocarcinoma of the colon/rectum * clinically staged T4 * written informed consent to surgery obtained Exclusion Criteria: * pregnancy * failure to perform colonic or rectal resection * synchronous cancer at time of colorectal cancer diagnosis
References
Publications (0)
Data not yet available